Global Gel Documentation Systems Market Grows Steadily at a CAGR of 4.04%

Introduction

A gel documentation system is a commonly used equipment in molecular biology laboratories for photographing and documenting nucleic acids and proteins. In addition, protein and nucleic acid are characterized using gel documentation systems. With modern imaging and documentation systems, nucleic acid and protein quantification can be highly precise and quantitative. The configurations of gel documentation systems vary based on throughput and sample type. Gel documentation systems quantify labeled nucleic acid and protein in various media, including cellulose, agarose, and acrylamide. For DNA/RNA detection, ethidium bromide or other nucleic acid strains stain the gel. Coomassie Brilliant Blue, Silver Staining, etc., are utilized to detect proteins.

Market Dynamics

Increasing Number of Population Genomics Initiatives Drives the Global Market

Extensive genomic research is being conducted globally to enable precision medicine in various aspects of healthcare, such as diagnostics, drug development, and patient stratification. Researchers can now conduct extensive studies and generate vast amounts of genomic data for further analysis and interpretation due to advances in sequencing technologies and software for genomic analysis. For example, in January 2020, Germany joined the "EU's 1+ Million Genomes Initiative" to actively participate in this research project to share genomic data across the European Union (EU) to develop future diagnostic and therapeutic methods for rare diseases. As a result of these advancements in the field of genomics, the use of genomic software solutions by various end users for data interpretation is anticipated to increase, driving the growth of the global gel documentation systems market in the coming years.

Novel Diagnostic Applications Creates Tremendous Opportunities

Novel ideas for the diagnosis and treatment of numerous human diseases are consistently produced by advances in understanding the human genome. As exhaustive research is conducted in genomics for clinical decision-making, industry titans also invest in developing sophisticated software algorithms for genomic data analysis. With genomics and data analysis advancing rapidly, it is essential to recognize the dynamic nature of this field. As a result, technologies are quickly becoming obsolete and replaced by newer technologies that enable a greater understanding of the complexities of genome behavior in healthy and diseased individuals. Due to technologies such as NGS, understanding the various aspects contributing to a thriving disease diagnosis is becoming faster and more accurate. These developments provide an unrivaled opportunity to significantly advance the diagnostics data analysis field and contribute to global market expansion.

Regional Analysis

North America is the most significant global gel documentation systems market shareholder and is estimated to exhibit a CAGR of 3.65% over the forecast period. North America dominates the global market for gel documentation systems and is anticipated to continue to do so. Numerous legacy healthcare organizations in North America are currently integrating their portfolios with advanced gel documentation systems. In addition, the increasing prevalence of gel documentation detection technology in the United States increases its applicability to large genetic data sets, resulting in actionable outcomes. Furthermore, developing advanced protein and nucleic acid quantification offers employment and financial development opportunities in North American research facilities. These factors are contributing to the expansion of the North American gel documentation systems market.

Europe is anticipated to exhibit a CAGR of 4.50% over the forecast period. Several European nations persistently work to improve genomics and bioinformatics research initiatives across the continent. For instance, launched in 2018, the "1+ Million Genomes" initiative is one of the largest collaborative projects in which 22 signatory EU member states and Norway collaborated to share genomic data across the EU for research purposes to develop future diagnostics and treatments for rare diseases. This EU-initiated project aims to enhance the accessibility, effectiveness, resilience, and sustainability of healthcare systems throughout the region. The initiative has ensured that scientific excellence is directed toward understanding the role of genomics in modulating human health, creating massive growth opportunities in the region as a large amount of data is generated, resulting in a rise in research institutions' adoption of gel documentation systems.

Key Highlights

• The global gel documentation systems market was valued at USD 298.10 million in 2022. It is estimated to reach USD 425.61 million by 2031, growing at a CAGR of 4.04% during the forecast period (2023–2031).
• Based on products, the global gel documentation systems market is divided into instruments, accessories, and software. The instruments segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 4.28% over the forecast period.
• Based on the source, the global gel documentation systems market is divided into ultraviolet (UV), light-emitting diodes (LEDs), laser, and others. The ultraviolet (UV) segment contributes to the highest market share and is expected to exhibit a CAGR of 5.07% over the forecast period.
• Based on detection technology, the global gel documentation systems market is divided into fluorescence, chemiluminescence, colorimetric, and other detection technologies. The fluorescence segment accounts for the largest market share and is anticipated to exhibit a CAGR of 4.40% over the forecast period.
• Based on application, the global gel documentation systems market is bifurcated into nucleic acid quantification, protein quantification, and others. The nucleic acid quantification segment owns the highest market share and is predicted to exhibit a CAGR of 4.30% over the forecast period.
• Based on the end-user, the global gel documentation systems market is bifurcated into academic and research institutions, pharmaceutical and biotech companies, hospitals and diagnostic laboratories, contract research organizations, and others. The academic and research institutions segment dominates the global market and is predicted to exhibit a CAGR of 4.57% during the forecast period.
• North America is the most significant global gel documentation systems market shareholder and is estimated to exhibit a CAGR of 3.65% over the forecast period.

Competitive Players

Competitive Players

The key players in the global gel documentation systems market are Analytik Jena GmbH, Azure Biosystems, Inc., Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Cleaver Scientific, Danaher Corporation, Clinx Science Instruments Co., Ltd., Endress + Hauser Group, LI-COR, Inc., NIPPON Genetics Europe, PerkinElmer, Inc., Merck KGaA, Syngene, Thermo Fisher Scientific Inc., and Vilber.

Recent Developments

Market News

• In September 2022, miniPCR bio, a manufacturer of scientific tools for educators and researchers, introduced the BanditTM STEM Electrophoresis Kit, an educational electrophoresis system. Bandit is a safe, inexpensive STEM activity kit that students can use to construct and operate a gel electrophoresis system, thereby gaining a thorough understanding of this essential laboratory instrument.
• In October 2022, Biotium, a prominent provider and developer of fluorescent tools for life science research, introduced the next generation's Gel-BrightTM Laser Diode Gel Illuminator. The light and optics equipment business OMEC Medical created the gel illuminator in collaboration with Biotium to provide a superior alternative to UV and LED-based gel imaging.

Segmentation

Global Gel Documentation Systems Market: Segmentation

By Products

• Instruments
• Accessories
• Software

By Source

• Ultraviolet (UV)
• Light Emitting Diodes (LEDs)
• Laser
• Others

By Detection Technology

• Fluorescence
• Chemiluminescence
• Colorimetric
• Other Detection Technologies

By Applications

• Nucleic Acid Quantification
• Protein Quantification
• Others

By End-User

• Academic and Research Institutions
• Pharmaceutical and Biotech Companies
• Hospitals and Diagnostic Laboratories
• Contract Research Organization
• Others

By Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World (RoW)